The Leadership Team at ImpriMed is responsible for setting the strategic direction and vision for the company, driving innovation in personalized medicine for pets with blood cancer. They oversee operational efficiency, foster partnerships, and ensure that the organization's goals align with its mission to provide accessible, advanced treatment options for pets in need.